FasL: a double-edged sword for tumor formation Differential effects of FasL on tumor formation Cell-cell contact suppresses Fas-mediated apoptosis Unconventional.

Slides:



Advertisements
Similar presentations
Cell-Mediated Effector Responses Chapter 14
Advertisements

The Notch-  -Secretase Pathway. Notch activation involves the proteolytic cleavage of the Notch ligand/receptor complex by  -secretase to release the.
Acquired Immune Response Sanjaya Adikari Department of Anatomy.
T cell & Rui He Department of Immunology Shanghai Medical School Fudan University T cell-mediated immunity.
The Story of Bcl-2 Linking cell apoptosis to tumor metastasis Crystal structure of Bcl-2 complex By Yaming Wang.
T cells Jan Novák. The immune system Protection against infectious agents Clearance of dying, damaged and dangerous cells Regulation of the immune responses.
Apoptosis 花瓣樹葉的凋零飄落 'Apoptosis' (pronounced as əpo΄tosis ) is of Greek origin, having the meaning "falling off or dropping off", in analogy to leaves falling.
1 Shaping T cell functions by tumor extracellular matrix. Bei-Chang Yang ( 楊倍昌 ) Institute of Basic Medical Sciences ( 基醫所 ), Department of Microbiology.
Tumor immunology Immune erosion
T cell-mediated immunity Chapter 8
To live or to die, that's a problem of Fas signal: 成功大學醫學院 微生物暨免疫學研究所 17/11/2004 張金瑛 王琳雅 吳怡靜 黃建勳 鄭柏吟 楊倍昌 蘇重禎 張雅南 黃偉倫 黃俊淵 林裕萍.
Cells of inflammation and Immunity G. Wharfe 2005.
Tumour immunology & immunotherapy
Cancer immunology and immunotherapy. First an aside  Oncogenes and tumor suppressor genes.  Definitions anyone?  Oncogene –  Tumor suppressor gene.
Emily Hodgson Hallmarks of Cancer Immunology Drugs Metastasis.
T lymphocytes Jianzhong Chen, Ph. D. Institute of Immunology, ZJU.
Enhancement Of T-Cell Immunity To Osteosarcoma By Modulation Of Programmed Death Receptor Pathway Pooja Hingorani, Danielle Lussier, Joseph Blattman.
Immune response and regulation 免疫应答 (immune response, Ir) Body receive stimulation from Ag , Specific lymphocytes recognize Ag , they activate, proliferate.
year Cancer/ Neuronal disorder Infection/Development 1 Tumor immunology BC Yang Expected life-span Immune capability 2010.
Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-regulation of Calreticulin Expression Speaker: Yi-Chien.
Cell-cell Communications in Development
STAT3 and the Immune System Maureen Sherry Lynes February 29, 2012.
Unit 2 seminar: Adaptive immunity T & B lymphocytes Reminders: -Use references in discussion and be sure to rephrase information in your own words -Evaluate.
FasDR (CD95) in many cancers, in particular Non-Hodgkin’s Lymphoma Benjamin Badger.
Characteristics of Cancer. Promotion (reversible) Initiation (irreversible) malignant metastases More mutations Progression (irreversible)
Catch Me, --Mechanisms of Tumor Immune Escape maker 李龙 商亮 孙健 宋春艳 郁舒靓 李丽丽 If You Can.
1 Shaping immune responses by extracellular matrix. Bei-Chang Yang, Ph.D. ( 楊倍昌 ) Department of Microbiology and Immunology, College of Medicine, National.
1 Fas Ligand: switching signals from tumor immune erosion to metastasis Bei-Chang Yang, Ph.D. ( 楊倍昌 ) Professor, Department of Microbiology and Immunology,
Jianzhong Chen, Ph.D. Institute of Immunology, ZJU.
The life history of T lymphocytes Precursors mature in the thymus Naïve CD4+ and CD8+ T cells enter the circulation Naïve T cells circulate through lymph.
Bcy1 New insight in death signaling: on Fas and FasL Bei-Chang Yang, Ph.D. ( 楊倍昌 ) Department of Microbiology and Immunology, College of Medicine, National.
1 Molecular Mechanisms for gp160-Enhanced Apoptosis Keith J. Micoli, Olga A. Mamaeva, George Pan, Eric Hunter and Jay M. McDonald University of Alabama.
Lecture #10 Aims Describe T cell maturation and be able to differentiate naïve and effector T cells. Differentiate the development and functions of Th1.
Tumor immunotherapy 张沛张书铭 张黎明 赵宸 赵世刚 Tumour Immunotherapy: questions Can immune stimulators combat cancer? Which forms of immunotherapy can be used?
MICR 304 Immunology & Serology Lecture 6 NK Cells, Lymphocytes Chapter 1.4 –1.17; 2.30 – 2.33 Lecture 6 NK Cells, Lymphocytes Chapter 1.4 –1.17; 2.30 –
Apoptosis in Cancer By: Karen Hutcherson Ryan Jenkins Angie Lam Jennie Zaborsky ISAT
1 Shaping T cell functions by extracellular matrix. Bei-Chang Yang, Ph.D. ( 楊倍昌 ) Director, Department of Microbiology and Immunology, College of Medicine,
Innate immunity Part Ⅰ overview of innate immunity Part Ⅱ innate immune cells Part Ⅲ functions of innate immunity.
PLC activation Ca++ flux NF-AT / NFkB nuclear localization protein tyrosine phosphorylation IL-2 production proliferation cytokine production TCR internalization.
HOMING Ewing vs Paget Trapping vs homing (controlled arrest) “Seed and soil” Organ-specific metastatic colonization of favorable microenvironment.
Chapter 15.  Immunological tolerance is defined as unresponsiveness to an antigen that is induced by previous exposure to that antigen  Antigens that.
IMMUNOLOGICAL TOLERANCE. BASIC FACTS ABOUT TOLERANCE Tolerance – a state of unresponsiveness specific for a given antigen It is specific (negative) immune.
Cancer and the Immune System
Objectives Introduction Ags expressed by cancer cells
M1 – Immunology CYTOKINES AND CHEMOKINES March 26, 2009 Ronald B
Anne Philips Lab Meeting
Cellular Immune response
Yu-fang huang, yi-hui wu, cheng-yang chou*
Research, 2016, Vol. 4, No. 1, doi: /jfnr-4-1-6
T cell-mediated immunity
Volume 137, Issue 3, Pages e4 (September 2009)
Avoiding Immune Detection
T cell mediated immunity Part II
Extracellular Vesicles in Cancer: Cell-to-Cell Mediators of Metastasis
T cell mediated immunity
Heating is a multifunctional adjuvant that affects tumor microenvironment through several intrinsic and extrinsic mechanisms, which could enhance immunotherapy.
Differentiation and Functions of CD8+ Effector T Cells
HOMING
Isabel Barao, William J Murphy 
Volume 137, Issue 3, Pages e4 (September 2009)
T cell-mediated immunity
Mechanisms of immune escape in the tumor microenvironment.
Tumor Entrained Neutrophils Inhibit Seeding in the Premetastatic Lung
Heather L Maecker, Zhong Yun, Holden T Maecker, Amato J Giaccia 
Tumor-Associated Macrophages: From Mechanisms to Therapy
Figure 1. The activity of CD26/DPP4 in patient samples with lung adenocarcinoma. The measured activity is presented by ... Figure 1. The activity of CD26/DPP4.
Chie Kudo-Saito, Hiromi Shirako, Tadashi Takeuchi, Yutaka Kawakami 
Cell-mediated immunity Regulation of the immune response
Primary B16F10 tumor inhibits experimental metastasis formation in the lung. Primary B16F10 tumor inhibits experimental metastasis formation in the lung.
Experimental metastasis inhibition by primary tumors is mediated by NK cells and IFNγ. Experimental metastasis inhibition by primary tumors is mediated.
Presentation transcript:

FasL: a double-edged sword for tumor formation Differential effects of FasL on tumor formation Cell-cell contact suppresses Fas-mediated apoptosis Unconventional Fas signal for gene expression FasL reverse signaling 楊倍昌 國立成功大學醫學院 微生物及免疫學研究所 BC Yang

Fight cancer, But, sometimes we lose BC Yang

The great escape: Resistance to killing Defective Fas pathway Resistance to Granzyme Fas-L and Neutrophil Cytotoxic T cells Innate immunity BC Yang

Immune privilege or inflammation? Joe O'Connell et al. Nature Medicine 7, (2001) BC Yang

Caspase 3 Apaf-1 Caspase 9 Death substrates Apoptosis Nature 407, 789 – 795(2000) Nagata, S. (Fas); Krammer, P. (Apo1) CD95/CD95-L Transducing death signal Involving in cytotoxicity, immune homeostasis, tumor formation, etc. BC Yang

In vivo consequences of FasL expression by tumors (using over-expression system) Enhanced rejection Delayed rejection Renca, MH134, L5178Y, B16/BL6, CT26* Note: *:syngenic, nude, SCID # : allogenic, lpr Ref: Lejeune FJ et al., 1998, Curr. Op. Immunol. CT26 # B16-F10 BC Yang

FasL ribozyme /EGFP plasmid Hammerhead ribozyme. 54-mers. Inserted into the pEGFP-N1. Driven by CMV promoter. Chio CC, Wang YS, Chen YL, Lin SJ and Yang BC (2001) Down-regulation of Fas-L in glioma cells by ribozyme reduces cell apoptosis, tumor infiltrating cells, and liver damage but accelerates tumor formation in nude mice. Br J Cancer 85: BC Yang

U-373MG cells transfected with FasL ribozyme /EGFP plasmid Light microscopy Fluorescent microscopy Immunohistochemistry (tumor cells in tissue)  -tubulin Fas-ligand U373(v) U373(R) U118(v) U118(R) BC Yang

Tumor formation in nude mice FasL high FasL low Br J Cancer (2001) 85, 1185 Tumor cells T, B, Macrophages, monocytes, granulocytes, etc…. Stroma cells Blood vessels BC Yang

Q: How about the action of tumor FasL in immune intact mice? A: It is organ dependent! BC Yang

Animal model C57B/6 Melanoma cell line B6F10 Gene knockdown by FasL ribozyme Subcutis/lung BC Yang

Effect of FasL on growth and death of B16F10 cells Apoptosis in 3-day culture Cell growth rate BC Yang

Granulocytes mediates the Fas-L-associated apoptosis during lung metastasis of melanoma that determines the metastatic behavior (B16F10 in C57BL/6) Br J Cancer, 87: 359 (2002) BC Yang

Depletion of CD4, CD8 T cells and PMNs affected lung metastasis Vector controlsFas-L ribozyme What happened here? Br J Cancer, 87: 359 (2002) BC Yang

Control Fas-L ribozyme In subcutaneous environment: FasL on tumor cells mediates inactivation of neutrophils 5x10 5 cells subcutaneous injection FasL on tumor cells mediates inactivation of neutrophils. J. Immunol. (2003) 171: BC Yang

Vector controlsFas-L-ribozyme Depletion of CD4, CD8 T cells and PMNs affected subcutaneous tumor formation BC Yang

Tumor FasL high impairs neutrophil activation: gelatinase B, ROS, CD-11b, and FasL (In coculture for 24 h). Cell death Gelatinase B ROS J. Immunol. (2003) 171: BC Yang

Puzzles on tissue specificity (to be answered) Factors responsible for tissue specificity Function of immune cells in different tissues BC Yang

No death occurred in Jurkat cells during coculture with gliomas PI-staining AB CDE A: Jurkat cells alone B: CH-11 (1ng/ml) C: with U-118MG(V) D: with U118MG (R) E: ZB4 (100ng/ml)/CH-11 免疫細胞沒那麼容易死亡 : BC Yang

Coculture with tumor cells inhibits the Fas- mediated apoptosis. Can ECM play a role in this protection? BC Yang

Death pathway inhibited DISC formation reduced

U 118(V/R) Jurkat cells BC Yang Cell-cell contact is required and integrins involved.

Coculture with glioma cells/conditioned media did not reduced the surface Fas protein. BC Yang

Intracellular signaling induced by cell-cell contact : PI3K/AKT is important for suppression of Fas-mediated apoptosis in T cells

BC Yang Other anti-apoptosis genes

J Immunol. 2007, in revision BC Yang Phosphatidylinositol 3-Kinase/Akt activation by integrin-tumor matrix interaction suppresses Fas-mediated apoptosis in T cells

Fas/FasL interaction may create an immunosuppresive environment Induction of IL-10 in T cell lines upon contact with human glioma cells, that is mediated by Fas signaling through a PKA-independent pathway. J Immunol (2003) 171: BC Yang

Jurkat Molt IL-10  -actin Glioma-associated IL-10 induction in T cell lines BC Yang 1. control, Jurkat alone 2. Jurkat + U118MG 3. Jurkat + U373MG

U373(V/R) or U118(V/R) Jurkat cells IL-10  -actin Direct cell-to-cell contact is required 1. Jurkat alone 2. Jurkat separate chamber 3. Jurkat in upper chamber /coculture in low chamber 4. Jurkat in coculture U118(V) BC Yang

Fas/Fas-L signal-associated IL-10 induction Jurkat U-373MG U-118MG - V R V R IL-10  -actin Molt-4 U-373MG U-118MG - V R V R IL-10  -actin BC Yang

Fas FasL T cells Tumor Tissue environment ? Cytokines ? IL-10, IL-6, IL-8 Neutrophils To help or not to help ? To be solved BC Yang

FasL reverse signaling Suzuki I. and Fink PJ.. Maximal proliferation of cytotoxic T lymphocytes requires reverse signaling through Fas ligand. J. Exp. Med., 187:123, Boursalian TE, Fink PJ, Mutation in Fas Ligand Impairs Maturation of Thymocytes Bearing Moderate Affinity T Cell Receptors, J. Exp. Med., 198, 349, 2003 Sun M, Ames KT, Suzuki I,. Fink PJ, The Cytoplasmic Domain of Fas Ligand Costimulates TCR Signals, J.Immunol., 177, 1481, 2006 BC Yang

3T3-N13T3-FasL 3T3- △ 33 3T3-Fas 3T3- △ 70 FasL on lung metastases Manuscript in preparation; 2007 BC Yang